Rash severity and dose in phase I dose escalation cetuximab (C225) trial
Year: 2008
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: R. S. Sangha, C. Ho, L. Beckett, M. Tanaka, D. H. Lau, D. B. Eisen, P. C. Mack, R. A. Burich, D. R. Gandara, A. M. Davies
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W539813
